Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
ATP6V0A2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Invitae Connective Tissue Disorders Panel Invitae United States | 195 | 92 |
|
Invitae Supplemental Metabolic Newborn Screening Panel Invitae United States | 253 | 189 |
|
Invitae Brain Malformations Panel Invitae United States | 247 | 161 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins Hospital United States | 110 | 50 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Intergen Intergen Genetics and Rare Diseases Diagnosis Center Turkey | 1 | 1 |
|
Generalized, Partial and Atypical Lipodystrophy Panel PreventionGenetics United States | 57 | 29 |
|
Connective Tissue Disorders Panel PreventionGenetics United States | 166 | 101 |
|
ATP6V0A2 - Cutis laxa, autosomal recessive type IIA Translational Metabolic Laboratory Radboud University Medical Centre Netherlands | 2 | 1 |
|
Skin and Connective Tissue Disorders Panel PreventionGenetics United States | 125 | 69 |
|
Congenital Disorders of Glycosylation (CDG) Panel PreventionGenetics United States | 56 | 54 |
|
Lissencephaly and related disorders Comprehensive test HNL Genomics Connective Tissue Gene Tests United States | 46 | 42 |
|
Lissencephaly and related disorders Deletion / Duplication test HNL Genomics Connective Tissue Gene Tests United States | 46 | 42 |
|
Lissencephaly and related disorders NGS test HNL Genomics Connective Tissue Gene Tests United States | 46 | 42 |
|
Invitae Congenital Disorders of Glycosylation Panel Invitae United States | 203 | 152 |
|
Ehlers-Danlos Syndromes (EDS) Panel PreventionGenetics United States | 99 | 65 |
|
Congenital Disorders of Glycosylation Panel Baylor Genetics United States | 29 | 27 |
|
Baylor Genetics United States | 842 | 637 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.